Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent.
about
Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.Lithium Reversibly Inhibits Schwann Cell Proliferation and Differentiation Without Inducing Myelin Loss.pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway.
P2860
Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@en
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@nl
type
label
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@en
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@nl
prefLabel
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@en
Lithium chloride antileukemic ...... s GSK-3 and MEK/ERK dependent.
@nl
P2093
P2860
P50
P356
P1433
P1476
Lithium chloride antileukemic ...... is GSK-3 and MEK/ERK dependent
@en
P2093
F Zassadowski
O Chourbagi
R Ann Padua
P2860
P2888
P304
P356
10.1038/LEU.2015.159
P577
2015-06-25T00:00:00Z